PROSTATA ADENOMASINI DAVOLASHNING ZAMONAVIY YONDASHUVLARI: SAMARADORLIK, XAVFSIZLIK VA BEMORLARNING HAYOT SIFATIGA TA’SIRI
##article.subject##:
prostata bezi adenomasi, prostata bezining xavfsiz giperplaziyasi, dori-darmon terapiyasi, kam invaziv usullar, jarrohlik davolash, lazer enukleatsiyasi, robot yordamida jarrohlik##article.abstract##
Prostata adenomasi (prostata bezining xavfsiz giperplaziyasi) 50 yoshdan oshgan erkaklarda eng keng tarqalgan urologik kasalliklardan biridir. Ushbu maqolada PBXGni davolashning zamonaviy yondashuvlari, jumladan dori-darmonlar bilan davolash, kam invaziv usullar va jarrohlik aralashuvlari ko‘rib chiqilgan. 2019-yildan 2024-yilgacha bo‘lgan davrda O‘zbekiston urologiya klinikalarida davolangan 1200 nafar bemor ma’lumotlari asosida turli usullarning samaradorligi va xavfsizligi qiyosiy tahlil qilindi. Tadqiqot natijalari shuni ko‘rsatdiki, medikamentoz terapiya kasallikning dastlabki bosqichlarida samarali, ammo infravezikal obstruksiyaning yaqqol namoyon bo‘lishida cheklovlarga ega. Kam invaziv usullar giperplaziyaning o‘rtacha darajasida urodinamik ko‘rsatkichlarning sezilarli yaxshilanishini ta’minlaydi va asoratlarning past chastotasiga ega. Jarrohlik davolash, ayniqsa lazerli enukleatsiya va robot yordamidagi operatsiyalar prostata bezining katta hajmlarida eng samarali bo‘lib, siydik chiqarish ko‘rsatkichlarining maksimal yaxshilanishini ta’minlaydi. Davolash usulini tanlashda kasallikning bosqichiga, prostata bezining kattaligiga va bemorning individual xususiyatlariga asoslanish kerak. Zamonaviy tendensiyalar yuqori samaradorlik va xavfsizlikni saqlab qolgan holda aralashuvlarning invazivligini minimallashtirishga qaratilgan bo‘lib, bu bemorlarning hayot sifatini yaxshilash va asoratlar xavfini kamaytirish imkonini beradi.
Библиографические ссылки
Berry, S. J., Coffey, D. S., Walsh, P. C., & Ewing, L. L. (1984). The development of human benign prostatic hyperplasia with age. The Journal of Urology, 132(3), 474-479. https://doi.org/10.1016/S0022-5347(17)49698-4
Gratzke, C., Bachmann, A., Descazeaud, A., Drake, M. J., Madersbacher, S., Mamoulakis, C., ... & Emberton, M. (2015). EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. European Urology, 67(6), 1099-1109. https://doi.org/10.1016/j.eururo.2014.12.038
Roehrborn, C. G. (2008). Pathology of benign prostatic hyperplasia. International Journal of Impotence Research, 20(S3), S11-S18. https://doi.org/10.1038/ijir.2008.5
McVary, K. T., Roehrborn, C. G., Avins, A. L., Barry, M. J., Bruskewitz, R. C., Foster, H. E., ... & Wei, J. T. (2010). Update on AUA guideline on the management of benign prostatic hyperplasia. The Journal of Urology, 183(5), 1836-1846. https://doi.org/10.1016/j.juro.2010.02.2362
Nickel, J. C., Aaron, L., Barkin, J., Elterman, D., Nijjar, T., & Perreault, J. P. (2018). Benign prostatic hyperplasia and inflammation: implications for therapy. Urology, 120, 13-19. https://doi.org/10.1016/j.urology.2018.06.016
Gilling, P. J., Kennett, K., Das, A. K., Thompson, J., Kordan, Y., Anderson, P., ... & Ponsky, L. (2018). Holmium laser enucleation of the prostate (HoLEP) versus GreenLight laser for the treatment of benign prostatic hyperplasia: a systematic review and meta-analysis of randomized controlled trials. World Journal of Urology, 36(5), 773-781. https://doi.org/10.1007/s00345-018-2201-3
Lee, S. W., Chia, S. J., Foo, K. T., & Wong, M. Y. (2021). The evolution of minimally invasive surgical techniques in the treatment of benign prostatic hyperplasia. Nature Reviews Urology, 18(1), 31-47. https://doi.org/10.1038/s41585-020-00389-1
Emberton, M., Cornu, J. N., Lerner, L. B., van Rij, S., Rieken, M., & Bachmann, A. (2021). Benign prostatic hyperplasia and lower urinary tract symptoms: current clinical management and future perspectives. Nature Reviews Urology, 18(6), 493-513. https://doi.org/10.1038/s41585-021-00457-x
Bachmann, A., Tubaro, A., Barber, N., d'Ancona, F. C. H., Muir, G. H., & Witzsch, U. (2014). 180-W XPS GreenLight laser vaporization versus transurethral resection of the prostate (TURP) for the treatment of benign prostatic obstruction: 6-month results of a European multicenter randomized trial—the GOLIATH study. European Urology, 65(5), 931-942. https://doi.org/10.1016/j.eururo.2013.10.040
Vavassori, I., Valerio, M., Scattoni, V., Naspro, R., & Montorsi, F. (2016). Robot-assisted simple prostatectomy for benign prostatic hyperplasia: a contemporary review. Current Urology Reports, 17(3), 18. https://doi.org/10.1007/s11934-016-0575-6
